Manufacturing / 5 Top Pharma Manufacturers in Puerto Rico
A long list of multinational pharma companies count Puerto Rico as one of their top manufacturing bases, including…
AMERICAS
Digitalization / Puerto Rico: Harnessing Technology in Pharma Manufacturing
Three heads of manufacturing for big pharma affiliates in Puerto Rico elaborate on how digital technology is…
Top 20 Pharma Companies in Puerto Rico
The top 20 pharmaceutical companies in Puerto Rico in the year leading up to December 2017 ranked by sales, with…
Cell & Gene Therapy / US FDA's Efforts to Advance the Development of Gene Therapy
Peter Marks, director of the US FDA’s Center for Biologics Evaluation and Research, outlines how the…
Talent / Pharma Leadership Strategies for Brazil
Three seasoned pharma executives with a wealth of experience working in Brazil offer their insights on leadership…
Top 20 Drugs in the USA 2018
The bestselling drugs of 2018 in the USD 485 billion US pharma market. The list features several major blockbusters…
Cybersecurity / A Health Business Risk Requiring Executive Leadership
Carla Smith looks at the various cybersecurity risks that exist across the US healthcare continuum and the steps…
Adherence / After the Prescription Is Written, Another Challenge: Abandonment
The AAM’s Chip Davis tackles the issue of abandonment within US healthcare and proposes three measures to boost…
Research Partnerships / Novartis Teams Up to Tackle Neglected Diseases in Brazil
Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research…
In Conversation
Christopher P. Molineaux – President & CEO, Life Sciences Pennsylvania, USA
Christopher P. Molineaux of Life Sciences Pennsylvania outlines the Keystone State’s rich lineage of pharmaceutical innovation, how the association is building inter-state and international connections, and why Philadelphia is justified in branding itself as the ‘Cellicon Valley’. We are at the epicentre of cell and gene therapy, what we are calling ‘Cellicon Valley’. Nowhere else boasts such a concentration…
Pharma Faces
Mark Trudeau
President, CEO | Mallinckrodt
President, CEO | Mallinckrodt
Ivan Lugo
Executive Director | INDUNIV
Executive Director | INDUNIV
Kenneth Carleton Frazier
CEO | Merck
CEO | Merck
Latest Reports
Focus on Colombia
Colombia: The Great Indian Investment Wave
With the onset of universal public healthcare, new types of foreign actors have…
Colombia: Ramping up the Local Footprint
With Latin America’s best healthcare system in terms of both coverage and…
Read more from Colombia >>
Focus on USA
The Fight Against Superbugs Heats Up
Boston University School of Law’s Kevin Outterson* looks at how cost-saving…
The Role of Patient Associations in Rare Disease Drug…
Monica Weldon, CEO and president of Bridge the Gap – SYNGAP Education and…
Read more from USA >>
Focus on Brazil
Novartis Teams Up to Tackle Neglected Diseases in Brazil
Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation…
Pharma Leadership Strategies for Brazil
Three seasoned pharma executives with a wealth of experience working in Brazil…
Read more from Brazil >>
Focus on Puerto Rico
Pharma Faces: Jorge Rodríguez, PACIV, Puerto Rico
Over the last 22 years, Jorge Rodríguez has grown Puerto Rican industrial…
Romark: Heading the New Wave of Puerto Rican Pharma…
Headquartered in Tampa, Florida, Romark focuses on developing innovative…
Read more from Puerto Rico >>
Focus on Mexico
The Ideal Pharma Country Manager: Mexico (Korn Ferry)
What traits, competencies and drivers do you need to be a successful pharma…
Fighting Corruption in Mexican Pharma
Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma…
Read more from Mexico >>
Focus on Canada
Biogen Canada’s Marina Vasiliou: A 100% Commitment to…
Marina Vasiliou took the reins as managing director of Biogen Canada in November…
Collective Impact in the Health Charity Sector
Diabetes Canada's Jan Hux outlines how her organization has been able to shift…
Read more from Canada >>
Legal Q&As
Regulatory Reform: Chile
An insight into upcoming regulatory reforms affecting Chile pharma. Prepared in association with Carey, a leading…
Product Liability: Uruguay
The legal framework for product liability in Uruguay. Prepared in association with FERRERE, a leading law firm in…
Regulatory Reforms: Peru
Regulatory reforms in Peru – an overview. Prepared in association with Osterling Abogados, a leading global…
A New Era in Access to Rare Disease Drugs in Canada
Durhane Wong-Rieger is the President & CEO of the Canadian Organization for Rare Disorders (CORD). In her first…
Comprehensive Access to Medicines should be the Priority for National Pharmacare…
Canada is the only developed country with a universal healthcare system that does not provide universal coverage of…
Brazilian Pharma: An Industry on a High
“Brazil undoubtedly holds great development opportunities for the global pharmaceutical and healthcare…
Cannabis / US FDA CBD Approvals Set to Soar
Sophia Ononye outlines the history of cannabis as a medicine in the US and, following the first FDA approval of a…
Did you Know? / Medtech in Puerto Rico
Four top facts you may have missed about Puerto Rico’s medical device manufacturing industry. Fact 1:…
Manufacturing / Romark: Heading the New Wave of Puerto Rican Pharma Manufacturing
Headquartered in Tampa, Florida, Romark focuses on developing innovative treatments for infectious diseases and the…